Skip to main content
Veterinary Medicines

NOBIVAC KC

Authorised
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live

Product identification

Medicine name:
НОБИВАК KC
NOBIVAC KC
Active substance:
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain B-C2, Live
    9.70
    log10 colony forming unit(s)
    /
    0.40
    millilitre(s)
  • Canine parainfluenza virus, strain Cornell, Live
    5.80
    log10 50% tissue culture infectious dose
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Nasal drops, lyophilisate and solvent for suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AF
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1504
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/10/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/10/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/10/2024